158 related articles for article (PubMed ID: 25455875)
1. Follow-up to genome-wide linkage and admixture mapping studies implicates components of the extracellular matrix in susceptibility to and size of uterine fibroids.
Aissani B; Zhang K; Wiener H
Fertil Steril; 2015 Feb; 103(2):528-34.e13. PubMed ID: 25455875
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata.
Eggert SL; Huyck KL; Somasundaram P; Kavalla R; Stewart EA; Lu AT; Painter JN; Montgomery GW; Medland SE; Nyholt DR; Treloar SA; Zondervan KT; Heath AC; Madden PA; Rose L; Buring JE; Ridker PM; Chasman DI; Martin NG; Cantor RM; Morton CC
Am J Hum Genet; 2012 Oct; 91(4):621-8. PubMed ID: 23040493
[TBL] [Abstract][Full Text] [Related]
3. Admixture mapping of uterine fibroid size and number in African American women.
Bray MJ; Edwards TL; Wellons MF; Jones SH; Hartmann KE; Velez Edwards DR
Fertil Steril; 2017 Dec; 108(6):1034-1042.e26. PubMed ID: 29202956
[TBL] [Abstract][Full Text] [Related]
4. Multiple hits for the association of uterine fibroids on human chromosome 1q43.
Aissani B; Wiener H; Zhang K
PLoS One; 2013; 8(3):e58399. PubMed ID: 23555580
[TBL] [Abstract][Full Text] [Related]
5. Admixture mapping of genetic variants for uterine fibroids.
Zhang K; Wiener H; Aissani B
J Hum Genet; 2015 Sep; 60(9):533-8. PubMed ID: 26040208
[TBL] [Abstract][Full Text] [Related]
6. Transethnic and race-stratified genome-wide association study of fibroid characteristics in African American and European American women.
Bray MJ; Wellons MF; Jones SH; Torstenson ES; Edwards TL; Velez Edwards DR
Fertil Steril; 2018 Sep; 110(4):737-745.e34. PubMed ID: 30196971
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
Karmon AE; Cardozo ER; Rueda BR; Styer AK
Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
[TBL] [Abstract][Full Text] [Related]
9. FASN, dietary fat intake, and risk of uterine leiomyomata in the Black Women's Health Study.
Wise LA; Palmer JR; Rosenberg L; Haddad SA; Ruiz-Narváez EA
Fertil Steril; 2016 Oct; 106(5):1136-1141. PubMed ID: 27375065
[TBL] [Abstract][Full Text] [Related]
10. Genetic Association Studies in Uterine Fibroids: Risk Alleles Presage the Path to Personalized Therapies.
Gallagher CS; Morton CC
Semin Reprod Med; 2016 Jul; 34(4):235-41. PubMed ID: 27513025
[TBL] [Abstract][Full Text] [Related]
11. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.
Islam MS; Protic O; Ciavattini A; Giannubilo SR; Tranquilli AL; Catherino WH; Castellucci M; Ciarmela P
Fertil Steril; 2014 Aug; 102(2):597-606. PubMed ID: 24934492
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids.
Fischer C; Juhasz-Boess I; Lattrich C; Ortmann O; Treeck O
Gynecol Endocrinol; 2010 Jan; 26(1):4-9. PubMed ID: 19639498
[TBL] [Abstract][Full Text] [Related]
13. A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids.
Cha PC; Takahashi A; Hosono N; Low SK; Kamatani N; Kubo M; Nakamura Y
Nat Genet; 2011 May; 43(5):447-50. PubMed ID: 21460842
[TBL] [Abstract][Full Text] [Related]
14. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
[TBL] [Abstract][Full Text] [Related]
17. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
[TBL] [Abstract][Full Text] [Related]
18. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
[TBL] [Abstract][Full Text] [Related]
19. A multi-stage genome-wide association study of uterine fibroids in African Americans.
Hellwege JN; Jeff JM; Wise LA; Gallagher CS; Wellons M; Hartmann KE; Jones SF; Torstenson ES; Dickinson S; Ruiz-Narváez EA; Rohland N; Allen A; Reich D; Tandon A; Pasaniuc B; Mancuso N; Im HK; Hinds DA; Palmer JR; Rosenberg L; Denny JC; Roden DM; Stewart EA; Morton CC; Kenny EE; Edwards TL; Velez Edwards DR
Hum Genet; 2017 Oct; 136(10):1363-1373. PubMed ID: 28836065
[TBL] [Abstract][Full Text] [Related]
20. Mifepristone inhibits extracellular matrix formation in uterine leiomyoma.
Patel A; Malik M; Britten J; Cox J; Catherino WH
Fertil Steril; 2016 Apr; 105(4):1102-10. PubMed ID: 26776909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
